ClinicalTrials.gg
RecruitingNCT06247878Updated Feb 8, 2024

Skiin-PSG Sleep Apnea

An observational study in Obstructive Sleep Apnea, sponsored by Myant Medical Corp.. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-08.

Sponsored by Myant Medical Corp. · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 133 studies in Sleep Apnea, Obstructive with a site in Canada — 22 open to participants now, 31 under way, 4 of them phase 3. Sleep Apnea, Obstructive · Canada.

Planned enrollment
9th of 31
200 · median 100
Started
2024
with 5 others
Observational
31 of 133
8 open now
Primary completion
2024-10
later than 2 of 30 live
Registered
116th of 133
by date

Among the 133 studies in Sleep Apnea, Obstructive with a site in Canada, this one is the 9th largest by planned enrollment of the 31 observational ones that give a count, is one of 6 that started in 2024, is one of 31 observational ones, reaches primary completion later than 2 of the 30 other live ones, and was the 116th registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

22 of the 133 studies in Sleep Apnea, Obstructive with a site in Canada are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 133 studies in Sleep Apnea, Obstructive with a site in Canada, or all of them as a file.
02

Study summary

The goal of this observational study is to develop new algorithms to detect apnea and/or hypopnea to provide additional insights to Skiin users and to their circle of care to validate and/or improve the current algorithms of the Skiin system for extraction of biological metrics during sleep based on the Skiin ECG and accelerometry data.

Read the detailed description

Eligible individuals who consent to participate will be asked to wear a Skiin Underwear chest band while going through a polyssomnography test.

  1. Investigational device

    The Skiin underwear chest band is worn at the under-chest level (under the pectoral or breast fold), and is connected to the Skiin Connected Life App (SCLA). The app collects ECG, accelerations, and temperature to generate metrics such as sleep, activity, and other physiological biometrics (resting heart rate, heart rate variability, breathing rate). The investigator will ensure the chest band is worn properly as defined by the vertical line on the band besides the Skiin logo corresponding with the center of the body.

  2. Polysomnography

The equipment being used for polysomnography is the Embla Sandman Elite PSG System. In advance to the test, patients receive information about the PSG test procedure and patients are usually instructed to avoid naps and stimulants (i.e., caffeine) during the day of the test. A list of instructions is usually provided to the patient.

Once the patient is ready for bed, the technologists will place sensors on the patient's scalp, temples, chest and legs using a mild adhesive, such as glue or tape. The sensors are connected by wires to a computer (wires are long enough to let the patient move around in bed). A small clip is placed on the finger or ear to monitor the level of oxygen in the blood.

Electrodes location - monitoring location includes:

  • Electroencephalography (EEG) - The placement of the EEG electrodes on the scalp follows an international system known as the 10-20 system of electrode placement. This is a standardized method of identifying equally spaced electrode positions on the scalp, based on four identifiable skull landmarks.
  • Electromyography (EMG) - Chin EMG records muscle tone at the mentalis and submentalis muscles. For the leg EMG two electrodes are placed about 2 to 4 cm apart longitudinally, along the belly of the anterior tibialis muscle of each leg, to record periodic limb movements.
  • Electrooculography (EOG) - to record rapid eye movements of REM sleep and to assess sleep onset.
  • Electrocardiography (ECG) - gel electrodes applied to the right and left subclavicular areas (essentially lead I) or the right subclavicular area and the lower left thorax (essentially lead II).
  • Airflow (nasal/oral) - thermal sensors or pressure sensing
  • Pulse oximetry - oximeter placed on the index finger
  • Respiratory effort (thoracic/abdominal) - belts placed around the chest and abdomen to monitor movements.
  • Snore sensor - small microphone
  • Body position - monitoring with sensors

Bio-calibration - is a series of actions that the patient is asked to perform before initiating the PSG test. This is to ensure that the sensors are measuring what they are supposed to and to verify signal quality.

Audio-visual recording - video and audio recording is part of the clinic's standard PSG test. It allows the clinician to observe the patient's behavior during the sleep study to improve clinical interpretation and diagnosis.

03

Conditions studied

  • Obstructive Sleep Apnea

Keywords

  • wearable electronic devices
  • digital health
  • sleep apnea
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study will recruit 200 individuals > 18 years old, referred to a polysomnography test due to a diagnosed or suspected obstructive sleep apnea.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals referred to do a polysomnography
  • Diagnosed or suspected obstructive sleep apnea (OSA)
  • 18 years old or more
  • Understand and speak English enough to consent

Exclusion criteria

Exclusion Criteria:

  • Pregnant women
  • Implanted defibrillator or pacemaker
  • Absence of a garment fitting the participant's body
  • An open wound or dressing (e.g. band-aid) on a body part that needs to be in contact with the Skiin electrodes
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Sleep apnea/hypopnea detection

    Ability of Skiin underwear chest band in detecting sleep apnea or hypopnea will be tested against polysomnography.

    Device: Skiin underwear chest band

Interventions

  • DeviceSkiin underwear chest band

    Participants will be asked to wear a skiin underwear chest band during a polysomnography test.

06

What researchers measure

Primary outcomes

  1. Accuracy of Skiin system for detection of apnea/hypopnea compared to Polysomnography

    Apnea/hypopnea events identified in the Skiin system will be compared to Apnea/hypopnea events identified in the polysomnography system. Data will be categorized as true positive, false positive, false negative to calculate the sensitivity, specificity, PPV, NPV).

    Time frame: Over one night, 8 to 12 hours total

Secondary outcomes

  1. Accuracy of Skiin system for detection of sleep duration compared to Polysomnography

    Sleep duration recorded by the Skiin system will be compared to Sleep duration recorded by the Polysomnography system to assess accuracy. Differences, bias, and Root Mean Square Error will be calculated for each participant and for the group.

    Time frame: Over one night, 8 to 12 hours total

  2. Accuracy of Skiin system for estimation of breathing rate compared to Polysomnography

    Resting breathing rate calculated by the Skiin system over night will be compared to resting breathing rate calculated by the Polysomnography for accuracy check. Differences, bias, and Root Mean Square Error will be calculated for each participant and for the group.

    Time frame: Over one night, 8 to 12 hours total

  3. Accuracy of Skiin system for calculation of resting heart rate compared to Polysomnography

    Resting heart rate calculated by the Skiin system over night will be compared to resting heart rate calculated by the polysomnography for accuracy check. Differences, bias, and Root Mean Square Error will be calculated for each participant and for the group.

    Time frame: Over one night, 8 to 12 hours total

  4. Accuracy of Skiin system for calculation of heart rate variability compared to polysomnography

    Heart rate variability (RMSSD) calculated by the Skiin system over night will be compared to heart rate variability calculated based on the polysomnography system's data. Differences, bias, and Root Mean Square Error will be calculated for each participant and for the group.

    Time frame: Over one night, 8 to 12 hours total

07

Study locations

1 of 1 sites recruiting
  • International Sleep Clinic WPSHC
    Parry Sound, Ontario P2A 3A4, Canada
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2024 (actual). Primary completion is estimated for Oct 2024, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 9, 2024
First posted
Feb 8, 2024
StartActual
Feb 1, 2024
Primary completionEst.
Oct 1, 2024
CompletionEst.
Feb 2, 2025
Last update
Feb 8, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06247878
Lead sponsor
Myant Medical Corp.
Collaborators
Jodha Tishon Inc
Responsible party
Sponsor
First posted
Feb 8, 2024
Start date
Feb 1, 2024
Primary completion
Oct 1, 2024 (estimated)
Completion
Feb 2, 2025 (estimated)
Last update
Feb 8, 2024

Study contacts

Colin Shapiro, MD
Contact
colinshapiro@rogers.com
416-551-829
Naheed Hossain
Contact
naheedkhossain@jodhatishon.com
647-291-5800
Colin Shapiro, MD
principal investigator · Jodha Tishon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion